Amgen 2012 Annual Report Download - page 98
Download and view the complete annual report
Please find page 98 of the 2012 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88 -
89 -
90 -
91 -
92 -
93 -
94 -
95 -
96 -
97 -
98 -
99 -
100 -
101 -
102 -
103 -
104 -
105 -
106 -
107 -
108 -
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
 |
 |
91
• Registration Statement (Form S-8 No. 333-138325) pertaining to the Amgen Inc. Amended and Restated Assumed Avidia
Equity Incentive Plan (formerly known as the Avidia, Inc. Amended and Restated 2003 Equity Incentive Plan);
• Registration Statement (Form S-4 No. 333-147482) relating to the possible exchange of unregistered Senior Floating
Notes for registered Senior Floating Notes relating to the Prospectus of Amgen Inc. for the registration of Senior Floating
Rate Notes due 2008, 5.85% Senior Notes due 2017, 6.375% Senior Notes Due 2037;
• Registration Statements (Form S-3 Nos. 333-150290 and 333-172617) relating to debt securities, common stock,
preferred stock, warrants to purchase debt securities, common stock, preferred stock or depositary shares, rights to
purchase common stock or preferred stock, securities purchase contracts, securities purchase units and depositary shares
of Amgen Inc. and in the related Prospectuses; and
• Registration Statement (Form S-8 No. 333-176240) pertaining to the Amgen Profit Sharing Plan for Employees in
Ireland;
of our reports dated February 27, 2013, with respect to the consolidated financial statements and schedule of Amgen Inc.
and the effectiveness of internal control over financial reporting of Amgen Inc. included in this Annual Report (Form 10-K) for
the year ended December 31, 2012.
/s/ Ernst & Young LLP
Los Angeles, California
February 27, 2013